Fine Foods & Pharmaceuticals N.T.M. (BIT: FF) financial statements
The consolidated income statement, balance sheet and cash flow statement of Fine Foods & Pharmaceuticals N.T.M. for its last 5 fiscal years, as filed with the regulator, in millions of euros. At the end of fiscal 2025 it had €280.0m in total assets and €134.2m in equity.
Income statement
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | €253.5m | €245.1m | €252.9m | €208.3m | €195.2m |
| Operating profit | €16.4m | €14.6m | €1.1m | −€1.0m | €5.0m |
| Finance costs | €3.0m | €3.5m | €5.0m | €2.2m | €0.8m |
| Profit before tax | €13.6m | €11.8m | −€1.9m | −€14.2m | −€4.6m |
| Income tax | €3.5m | €3.7m | €1.7m | −€4.7m | −€3.2m |
| Net profit | €10.1m | €8.2m | −€3.5m | −€9.5m | −€1.4m |
| Earnings per share | €0.41 | €0.32 | −€0.14 | −€0.37 | −€0.06 |
| Diluted earnings per share | €0.41 | €0.32 | −€0.14 | −€0.37 | −€0.06 |
| Depreciation and amortisation | €18.0m | €15.8m | €21.2m | €16.4m | €14.5m |
Balance sheet
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | €280.0m | €242.6m | €241.6m | €299.8m | €302.8m |
| Current assets | €117.4m | €96.4m | €111.4m | €164.7m | €171.6m |
| Inventories | €35.0m | €31.9m | €42.5m | €40.4m | €35.1m |
| Property, plant and equipment | €144.2m | €126.1m | €106.9m | €104.2m | €102.9m |
| Goodwill | €11.5m | €11.5m | €11.5m | €15.9m | €15.9m |
| Cash | €38.9m | €19.2m | €19.0m | €10.2m | €17.1m |
| Current liabilities | €67.2m | €70.7m | €101.4m | €84.0m | €109.7m |
| Equity | €134.2m | €132.1m | €126.9m | €133.3m | €147.2m |
| Equity including minorities | €134.2m | €132.1m | €126.9m | €133.3m | €147.2m |
Cash flow statement
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | €31.8m | €45.9m | €18.5m | €3.7m | −€5.8m |
| Investing cash flow | −€35.8m | −€31.6m | €45.9m | −€15.3m | −€36.3m |
| Financing cash flow | €23.8m | −€14.1m | −€55.7m | €4.7m | €56.0m |
| Capital expenditure | €34.6m | €33.9m | €18.1m | €15.0m | €14.8m |
| Dividends paid | €3.4m | €2.9m | €2.5m | €3.9m | €3.2m |
Where each figure comes from
From the annual report Fine Foods & Pharmaceuticals N.T.M. files every year in the European single electronic format (ESEF). The filing for each fiscal year: 2025 · 2024 · 2023 · 2022. If an item is not tagged in the filing, it is not in the table. The summary of the last fiscal year is on the Fine Foods & Pharmaceuticals N.T.M. page.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.